Episodes 31-45 of 617
Prostate Cancer Care: Testosterone Therapy’s Impact on Biochemical Recurrence
On the Frontlines of Prostate CancerProstate Cancer Care: Testosterone Therapy’s Impact on Biochemical Recurrence
Reevaluating Testosterone: A Paradigm Shift in Prostate Cancer Treatment
On the Frontlines of Prostate CancerReevaluating Testosterone: A Paradigm Shift in Prostate Cancer Treatment
Examining the Role of Bacterial Biofilms in Colorectal Cancer Screening
Clinician's RoundtableExamining the Role of Bacterial Biofilms in Colorectal Cancer Screening
Slowing Prostate Cancer Progression: The Role of Dietary Fat Modifications
On the Frontlines of Prostate CancerSlowing Prostate Cancer Progression: The Role of Dietary Fat Modifications
Early-Stage Prostate Cancer Treatment: Examining Long-Term Complications
On the Frontlines of Prostate CancerEarly-Stage Prostate Cancer Treatment: Examining Long-Term Complications
Advancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies
Project Oncology®Advancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies
From Diagnosis to Treatment: Challenges in Glioblastoma Care
NeuroFrontiersFrom Diagnosis to Treatment: Challenges in Glioblastoma Care
Anemia in CKD: Understanding the KDIGO 2025 Clinical Practice Guideline
Clinician's RoundtableAnemia in CKD: Understanding the KDIGO 2025 Clinical Practice Guideline
Etranacogene Dezaparvovec for Hemophilia B: Efficacy and Safety Four Years Post-Infusion
Clinician's RoundtableEtranacogene Dezaparvovec for Hemophilia B: Efficacy and Safety Four Years Post-Infusion
Screening Modalities for Colon Cancer: What You Need to Know
GI InsightsScreening Modalities for Colon Cancer: What You Need to Know
Melanoma Treatment Breakthroughs: Improving Long-Term Survival
Medical Industry FeatureMelanoma Treatment Breakthroughs: Improving Long-Term Survival
An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Spotlight On Subcutaneous Cancer ImmunotherapiesAn Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
Project Oncology®Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy
Project Oncology®AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Spotlight On Subcutaneous Cancer ImmunotherapiesNanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
